Drug recall · November 1, 2017
Fluocinonide Gel USP recall
Why: Cross contamination with other products: traces of Dapsone were found in the finished product.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Fluocinonide Gel USP, 0.05%, 15 g tube, Rx Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton Ontario Canada L6T1C1, Dist. by: Taro Pharmaceuticals U.S.A . Inc. Hawthorne NY 10532, NDC 51672-1279-1
- Lots / codes
Lot #: A771026850, Exp 6/18
- Quantity
- 16,944 tubes
- Company
- Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
- Distribution
- Nationwide
- Initiated
- September 20, 2017 · Voluntary: Firm initiated
- Classified
- December 29, 2017
- Reported
- November 1, 2017
- Ended
- September 10, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fluocinonide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.